Reviewing the occurrence of large genomic rearrangements in patients with inherited cancer predisposing syndromes: importance of a comprehensive molecular diagnosis

被引:2
作者
Rocha, Debora Leite [1 ]
Ashton-Prolla, Patricia [1 ,2 ,3 ]
Rosset, Clevia [1 ]
机构
[1] Hosp Clin Porto Alegre HCPA, Serv Pesquisa Expt, Lab Med Genom, Rua Ramiro Barcelos 2350, BR-90035930 Porto Alegre, RS, Brazil
[2] Univ Fed Rio Grande do Sul UFRGS, Dept Genet, Brazil Av Bento Goncalves, Programa Posgrad Genet & Biol Mol, Av Bento Goncalves 9500,Predio 43312 M, BR-91501970 Porto Alegre, RS, Brazil
[3] HCPA, Serv Genet Med, Rua Ramiro Barcelos 2350, BR-90035930 Porto Alegre, RS, Brazil
关键词
Cancer predisposition genes; cancer predisposition syndromes; large gene rearrangements; molecular diagnosis; molecular techniques; FAMILIAL ADENOMATOUS POLYPOSIS; HIGH-RISK BREAST; MUTYH-ASSOCIATED POLYPOSIS; TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU DISEASE; LI-FRAUMENI SYNDROME; RB1; GENE-MUTATIONS; OVARIAN-CANCER; TUBEROUS SCLEROSIS; LYNCH-SYNDROME;
D O I
10.1080/14737159.2022.2049247
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Introduction Hereditary cancer predisposition syndromes are caused by germline pathogenic or likely pathogenic variants in cancer predisposition genes (CPG). The majority of pathogenic variants in CPGs are point mutations, but large gene rearrangements (LGRs) are present in several CPGs. LGRs can be much more difficult to characterize and perhaps they may have been neglected in molecular diagnoses. Areas covered We aimed to evaluate the frequencies of germline LGRs in studies conducted in different populations worldwide through a qualitative systematic review based on an online literature research in PubMed. Two reviewers independently extracted data from published studies between 2009 and 2020. In total, 126 studies from 37 countries and 5 continents were included in the analysis. The number of studies in different continents ranged from 3 to 48 and for several countries there was an absolute lack of information. Asia and Europe represented most of the studies, and LGR frequencies varied from 3.04 to 15.06% in different continents. MLPA was one of the methods of choice in most studies (93%). Expert opinion The LGR frequencies found in this review reinforce the need for comprehensive molecular testing regardless of the population of origin and should be considered by genetic counseling providers.
引用
收藏
页码:319 / 346
页数:28
相关论文
共 203 条
[1]  
Agarwal R, 2014, DISCOV MED, V18, P331
[2]   Prevalence of BRCA1 genomic rearrangements in a large cohort of Italian breast and breast/ovarian cancer families without detectable BRCA1 and BRCA2 point mutations [J].
Agata, Simona ;
Viel, Alessandra ;
Della Puppa, Lara ;
Cortesi, Laura ;
Fersini, Giusi ;
Callegaro, Monia ;
Palma, Maurizia Dalla ;
Dolcetti, Riccardo ;
Federico, Massimo ;
Venuta, Salvatore ;
Miolo, Gianmaria ;
D'Andrea, Emma ;
Montagnas, Marco .
GENES CHROMOSOMES & CANCER, 2006, 45 (09) :791-797
[3]  
Ahani A, 2013, MOL VIS, V19, P454
[4]   RB1 gene mutations in retinoblastoma and its clinical correlation [J].
Ali, Mohammad Javed ;
Parsam, Vidya Latha ;
Honavar, Santosh G. ;
Kannabiran, Chitra ;
Vemuganti, Geeta K. ;
Reddy, Vijay Anand P. .
SAUDI JOURNAL OF OPHTHALMOLOGY, 2010, 24 (04) :119-123
[5]   BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group [J].
Alsop, Kathryn ;
Fereday, Sian ;
Meldrum, Cliff ;
deFazio, Anna ;
Emmanuel, Catherine ;
George, Joshy ;
Dobrovic, Alexander ;
Birrer, Michael J. ;
Webb, Penelope M. ;
Stewart, Colin ;
Friedlander, Michael ;
Fox, Stephen ;
Bowtell, David ;
Mitchell, Gillian .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2654-2663
[6]   TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes [J].
Andrade, Raissa Coelho ;
Evangelista dos Santos, Anna Claudia ;
de Aguirre Neto, Joaquim Caetano ;
Nevado, Julian ;
Lapunzina, Pablo ;
Vargas, Fernando Regla .
FAMILIAL CANCER, 2017, 16 (02) :243-248
[7]  
[Anonymous], 2020, NCCN Clinical Practice Guidelines in Oncology: Survivorship
[8]  
[Anonymous], 1988, NEUR C STAT, V45, P575
[9]   Adenomatous polyposis coli (APC):: a multi-functional tumor suppressor gene [J].
Aoki, Koji ;
Taketo, Makoto M. .
JOURNAL OF CELL SCIENCE, 2007, 120 (19) :3327-3335
[10]   Comprehensive BRCA mutation analysis in the Greek population. Experience from a single clinical diagnostic center [J].
Apessos, Angela ;
Agiannitopoulos, Konstantinos ;
Pepe, Georgia ;
Tsaousis, Georgios N. ;
Papadopoulou, Eirini ;
Metaxa-Mariatou, Vasiliki ;
Tsirigoti, Angeliki ;
Efstathiadou, Chrysoula ;
Markopoulos, Christos ;
Xepapadakis, Grigorios ;
Venizelos, Vasileios ;
Tsiftsoglou, Aris ;
Natsiopoulos, Loannis ;
Nasioulas, George .
CANCER GENETICS, 2018, 220 :1-12